CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on March 19, 2008
Clin J Am Soc Nephrol 3: 962-967, 2008
© 2008 American Society of Nephrology
doi: 10.2215/CJN.04971107

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.04971107v1
3/4/962    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Himmelfarb, J.
Right arrow Articles by Kellum, J. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Himmelfarb, J.
Right arrow Articles by Kellum, J. A.
Related Collections
Right arrowRelated Articles

Acute Renal Failure

Evaluation and Initial Management of Acute Kidney Injury

Jonathan Himmelfarb*, Michael Joannidis{dagger}, Bruce Molitoris{ddagger}, Miet Schietz§, Mark D. Okusa||, David Warnock, Franco Laghi**, Stuart L. Goldstein{dagger}{dagger}, Richard Prielipp{ddagger}{ddagger}, Chirag R. Parikh§§, Neesh Pannu||||, Suzana M. Lobo¶¶, Sudhir Shah***, Vincent D'Intini{dagger}{dagger}{dagger}, and John A. Kellum{ddagger}{ddagger}{ddagger}

* Maine Medical Center, Portland, Maine; {dagger} Medical University of Innsbruck, Innsbruck, Austria; {ddagger} Indiana University School of Medicine, Indianapolis, Indiana; § University Hospital Gasthuisberg, Leuven, Belgium; || University of Virginia, Charlottesville, Virginia; University of Alabama School of Medicine, Birmingham, Alabama; ** Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois; {dagger}{dagger} Department of Pediatrics, Baylor College of Medicine, Houston, Texas; {ddagger}{ddagger} Mayo Clinic, Minneapolis, Minnesota; § Yale University, New Haven, Connecticut; || University of Alberta, Edmonton, Alberta, Canada; Sao Jose Rio Preto Medical School, Sao Jose, Brazil; *** University of Arkansas, Little Rock, Arkansas; {dagger}{dagger}{dagger} Geelong Hospital, Geelong, Victoria, Australia; and {ddagger}{ddagger}{ddagger} University of Pittsburgh, Pittsburgh, Pennsylvania

Correspondence: Dr Jonathan Himmelfarb, Division of Nephrology, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102. Phone: 207-662-2417; Fax: 207-662-630; E-mail: himmej{at}mmc.org

The evaluation and initial management of patients with acute kidney injury (AKI) should include: (1) an assessment of the contributing causes of the kidney injury, (2) an assessment of the clinical course including comorbidities, (3) a careful assessment of volume status, and (4) the institution of appropriate therapeutic measures designed to reverse or prevent worsening of functional or structural kidney abnormalities. The initial assessment of patients with AKI classically includes the differentiation between prerenal, renal, and postrenal causes. The differentiation between so-called "prerenal" and "renal" causes is more difficult, especially because renal hypoperfusion may coexist with any stage of AKI. Using a modified Delphi approach, the multidisciplinary international working group, generated a set of testable research questions. Key questions included the following: Is there a difference in prognosis between volume-responsive and volume-unresponsive AKI? Are there biomarkers whose patterns (dynamic changes) predict the severity and recovery of AKI (maximal stage of AKI, need for RRT, renal recovery, mortality) and guide therapy? What is the best biomarker to assess prospectively whether AKI is volume responsive? What is the best biomarker to assess the optimal volume status in AKI patients? In evaluating the current literature and ongoing studies, it was thought that the answers to the questions posed herein would improve the understanding of AKI, and ultimately patient outcomes.


Related Articles

Setting the Agenda
Paul M. Palevsky
Clin. J. Am. Soc. Nephrol. 2008 3: 933-934. [Full Text] [PDF]

Setting the Agenda
Paul M. Palevsky
Clin. J. Am. Soc. Nephrol. 2008 3: 933-934. [Full Text] [PDF]



This article has been cited by other articles:


Home page
CJASNHome page
P. M. Palevsky
Setting the Agenda
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 933 - 934.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Nephrology.